We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drugmakers to Get More Details On Creating Trial Monitoring Plans
Drugmakers to Get More Details On Creating Trial Monitoring Plans
October 10, 2012
An upcoming FDA final guidance on risk-based monitoring of clinical investigations will include more specifics for drugmakers on developing monitoring plans, as industry has requested.